Manufacturing embraces IT as some drugmakers minimize R&D focus

Specialized IT systems, manufacturing execution systems, and data aggregation and analytics tools are coming together as some drugmakers turn their focus to manufacturing and away from R&D. Their objectives are to improve the quality and predictability of supply and to reduce production costs. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.